The Human Positive Cofactor 4 is a Promising Chemotherapeutic Target in Lung Adenocarcinoma

Figure 4

PC4 decreases lung adenocarcinoma sensitivity to cisplatin in vivo. H1299 vec and H1299 PC4 cells were subcutaneously injected into nude mice. Three mg/kg cisplatin was administered every 3 days. (a) The general image of tumor size. (b) The growth curves of tumors. (c) The weights of tumors in all groups. (d) Relative tumor weight was calculated to demonstrate the impact of PC4 on cisplatin sensitivity.  < 0.05.

(a)

(b)

(c)

(d)